Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Plant-derived extracellular vesicles show promise for delivering drugs and treating diseases.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Enhancing antioxidant responses can improve treatments for various diseases.

Cells from concentrated growth factor can become different cell types.

Gas-propelled microneedles can improve drug delivery efficiency and precision.

Improved CRBN ligands make protein degraders more effective and drug-like.

Reporter characteristics affect detection of hair loss from cancer therapy.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Further research is needed to develop effective cancer prevention strategies.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Cetuximab can cause excessive eyelash growth.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

3D models and organoids improve liposarcoma research and therapy development.

Medicinal plants have potential as alternative cancer treatments due to their ability to target and kill cancer cells.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

HPV16-transformed cells can change human skin cell properties, aiding tumor growth.

PRP injections improve intestinal healing in rabbits with fewer complications than soaking.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Finasteride does not prevent bladder cancer.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.